
Kyowa Hakko Kirin makes full use of cutting-edge biotechnologies based mainly on antibody engineering technology to create new pharmaceuticals to treat such diseases as cancer, kidney and immunologic diseases. We believe in making a contribution to enrich the health and lives of people throughout the world by expanding our operations globally from research, development and production to marketing.